OpenAlex
PricingAboutJobs
Log inGet started
Work

Design and synthesis of a highly selective, orally active and potent anaplastic lymphoma kinase inhibitor (CH5424802)

HTML

Year: 2011
Type: article
Source: Bioorganic & Medicinal Chemistry
DOI: 10.1016/j.bmc.2011.12.021
Authors: Kazutomo Kinoshita, Kohsuke Asoh, Noriyuki Furuichi, Toshiya Ito, Hatsuo Kawada, Sousuke Hara, Jun Ohwada, Takuho Miyagi, Takamitsu Kobayashi, Kenji Takanashi, Toshiyuki Tsukaguchi, Hiroshi Sakamoto, Takuo Tsukuda, Nobuhiro Oikawa
Institution: Chugai Pharmaceutical Co., Ltd. (Japan)
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: anaplastic lymphoma kinase, ALK inhibitors, side-chain optimization, kinase selectivity, oral bioavailability, non-small cell lung cancer, receptor tyrosine kinase, metabolic stability, clinical candidates
SDG: Good health and well-being

Open Access status: closed

Funder: U.S. Food and Drug Administration
OpenAlex ID: W2044936103
FWCI: 5.404
Cites: 17
Cited by: 180
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms